#BEGIN_DRUGCARD DB04640

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
581-75-9

# ChEBI_ID:
30893

# Chemical_Formula:
C10H8O6S2

# Chemical_IUPAC_Name:
naphthalene-2,6-disulfonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2007-09-11 11:49:07 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Naphthalene-2,6-disulfonic acid

# HET_ID:
BIH

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H8O6S2/c11-17(12,13)9-3-1-7-5-10(18(14,15)16)4-2-8(7)6-9/h1-6H,(H,11,12,13)(H,14,15,16)

# InChI_Key:
InChIKey=FITZJYAVATZPMJ-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4640

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
288.297

# Molecular_Weight_Mono:
287.976229368

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.9

# Predicted_LogS:
-2.9

# Predicted_Water_Solubility:
3.41e-01 g/l

# Primary_Accession_No:
DB04640

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
11390

# PubChem_Substance_ID:
46506948

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OS(=O)(=O)C1=CC2=CC=C(C=C2C=C1)S(O)(=O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
2,6-naphthalenedisulfonic acid
Ebert-Merz beta-acid
naphthalene-2,6-disulphonic acid

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:32 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M93720

# Drug_Target_1_GenBank_ID_Protein:
294165

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>951 bp
ATGGCACCAAAAGCAAAAATCGTTTTAGTTGGCTCAGGTATGATTGGAGGAGTAATGGCT
ACCTTAATTGTTCAGAAAAATTTAGGAGATGTAGTTTTGTTCGATATTGTAAAGAACATG
CCACATGGAAAAGCTTTAGATACATCTCATACTAATGTTATGGCATATTCAAATTGCAAA
GTAAGTGGTTCAAACACTTATGACGATTTGGCTGGAGCAGATGTAGTAATAGTAACAGCT
GGATTTACCAAGGCCCCAGGAAAGAGTGACAAAGAATGGAATAGAGATGATTTATTACCA
TTAAACAACAAGATTATGATTGAAATTGGTGGTCATATTAAGAAGAATTGTCCAAATGCT
TTTATTATTGTTGTAACAAACCCAGTAGATGTTATGGTACAATTATTACATCAACATTCA
GGTGTTCCTAAAAACAAGATTATTGGTTTAGGTGGTGTATTAGATACATCAAGATTGAAG
TATTACATATCTCAGAAATTAAATGTATGCCCAAGAGATGTAAATGCACACATTGTAGGT
GCTCATGGAAATAAAATGGTTCTTTTAAAAAGATACATTACTGTAGGTGGTATCCCTTTA
CAAGAATTTATTAATAACAAGTTAATTTCTGATGCTGAATTAGAAGCTATATTTGATAGA
ACTGTTAATACTGCATTAGAAATTGTAAACTTACATGCATCACCATATGTTGCACCAGCT
GCTGCTATTATCGAAATGGCTGAATCCTACTTAAAAGATTTGAAAAAAGTATTAATTTGC
TCAACCTTGTTAGAAGGACAATATGGACACTCCGATATATTCGGTGGTACACCTGTTGTT
TTAGGTGCTAATGGTGTTGAACAAGTTATCGAATTACAATTAAATAGTGAGGAAAAAGCT
AAATTTGATGAAGCCATAGCTGAAACTAAGAGAATGAAGGCATTAGCTTAA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
10187806	Read JA, Wilkinson KW, Tranter R, Sessions RB, Brady RL: Chloroquine binds in the cofactor binding site of Plasmodium falciparum lactate dehydrogenase. J Biol Chem. 1999 Apr 9;274(15):10213-8.
8515777	Bzik DJ, Fox BA, Gonyer K: Expression of Plasmodium falciparum lactate dehydrogenase in Escherichia coli. Mol Biochem Parasitol. 1993 May;59(1):155-66.
8901865	Dunn CR, Banfield MJ, Barker JJ, Higham CW, Moreton KM, Turgut-Balik D, Brady RL, Holbrook JJ: The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design. Nat Struct Biol. 1996 Nov;3(11):912-5.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2641

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34108

# Drug_Target_1_Name:
L-lactate dehydrogenase

# Drug_Target_1_Number_of_Residues:
316

# Drug_Target_1_PDB_ID:
1T2D

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_1_Protein_Sequence:
>L-lactate dehydrogenase
MAPKAKIVLVGSGMIGGVMATLIVQKNLGDVVLFDIVKNMPHGKALDTSHTNVMAYSNCK
VSGSNTYDDLAGADVVIVTAGFTKAPGKSDKEWNRDDLLPLNNKIMIEIGGHIKKNCPNA
FIIVVTNPVDVMVQLLHQHSGVPKNKIIGLGGVLDTSRLKYYISQKLNVCPRDVNAHIVG
AHGNKMVLLKRYITVGGIPLQEFINNKLISDAELEAIFDRTVNTALEIVNLHASPYVAPA
AAIIEMAESYLKDLKKVLICSTLLEGQYGHSDIFGGTPVVLGANGVEQVIELQLNSEEKA
KFDEAIAETKRMKALA

# Drug_Target_1_Reaction:
(S)-lactate + NAD+ = pyruvate + NADH + H+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
(S)-lactate + NAD(+) = pyruvate + NADH

# Drug_Target_1_SwissProt_ID:
Q27743

# Drug_Target_1_SwissProt_Name:
LDH_PLAFD

# Drug_Target_1_Synonyms:
EC 1.1.1.27
LDH-P

# Drug_Target_1_Theoretical_pI:
7.63

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AE008922

# Drug_Target_2_GenBank_ID_Protein:
21110939

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
XCC1738

# Drug_Target_2_Gene_Sequence:
>1329 bp
ATGGATGCTTGGCCCCGCTGTCTGGAACGTCTCGAAGCTGAATTCCCGCCCGAGGATGTC
CACACCTGGTTGAAACCCCTGCAGGCCGAAGATCGCGGCGACAGCATCGTGCTGTACGCG
CCGAACGCCTTCATTGTTGAGCAGGTCCGCGAGCGATACCTGCCGCGCATCCGCGAGTTG
CTGGCATATTTCGCCGGCAATGGCGAGGTGGCGCTGGCGGTCGGCTCCCGTCCGCGTGCG
CCGGAGCCGCTGCCGGCACCGCAAGCCGTCGCCAGTGCGCCGGCGGCCGCGCCGATCGTG
CCCTTCGCCGGCAACCTGGATTCGCATTACACCTTTGCCAACTTCGTGGAAGGCCGCAGC
AACCAGCTCGGTCTGGCCGCGGCGATCCAGGCCGCGCAGAAGCCGGGCGACCGTGCACAC
AACCCGTTACTGCTGTACGGCAGCACCGGGCTGGGCAAGACCCACCTGATGTTCGCGGCC
GGCAACGCGCTGCGCCAGGCCAATCCGGCGGCCAAGGTGATGTACCTGCGCTCGGAACAG
TTCTTCAGCGCGATGATCCGCGCGTTGCAGGACAAGGCAATGGACCAGTTCAAGCGCCAG
TTCCAGCAGATCGATGCGCTGCTGATCGACGACATCCAGTTTTTTGCCGGCAAGGACCGC
ACGCAGGAGGAGTTTTTCCACACCTTCAACGCGCTGTTCGACGGCCGCCAGCAGATCATC
CTGACCTGCGACCGCTATCCGCGCGAAGTCGAGGGCCTGGAGCCGCGGCTGAAGTCGCGC
CTGGCCTGGGGCCTGTCGGTGGCGATCGACCCGCCGGATTTCGAGACGCGTGCGGCGATC
GTGCTGGCCAAGGCGCGCGAGCGCGGCGCCGAGATTCCCGACGACGTGGCGTTTCTGATC
GCCAAGAAGATGCGCTCGAACGTGCGCGACCTGGAAGGGGCGCTCAACACGTTGGTGGCC
CGCGCCAACTTCACTGGCCGCTCGATCACTGTGGAGTTTGCGCAGGAGACGCTGCGTGAC
CTGTTGCGTGCGCAGCAGCAGGCGATCGGCATTCCCAACATCCAGAAGACCGTGGCCGAC
TACTACGGCCTGCAGATGAAGGACCTGCTTTCCAAGCGCCGCACCCGCTCATTGGCGCGC
CCGCGCCAGGTGGCGATGGCGCTCGCCAAGGAGTTGACCGAGCACAGCCTGCCGGAGATT
GGCGATGCGTTTGCCGGCCGCGACCACACCACCGTGCTGCACGCCTGCCGGCAGATCCGC
ACGCTGATGGAGGCCGACGGCAAGCTGCGCGAGGACTGGGAAAAGCTGATTCGCAAGCTC
AGCGAGTGA

# Drug_Target_2_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_2_General_References:
12024217	da Silva AC, Ferro JA, Reinach FC, Farah CS, Furlan LR, Quaggio RB, Monteiro-Vitorello CB, Van Sluys MA, Almeida NF, Alves LM, do Amaral AM, Bertolini MC, Camargo LE, Camarotte G, Cannavan F, Cardozo J, Chambergo F, Ciapina LP, Cicarelli RM, Coutinho LL, Cursino-Santos JR, El-Dorry H, Faria JB, Ferreira AJ, Ferreira RC, Ferro MI, Formighieri EF, Franco MC, Greggio CC, Gruber A, Katsuyama AM, Kishi LT, Leite RP, Lemos EG, Lemos MV, Locali EC, Machado MA, Madeira AM, Martinez-Rossi NM, Martins EC, Meidanis J, Menck CF, Miyaki CY, Moon DH, Moreira LM, Novo MT, Okura VK, Oliveira MC, Oliveira VR, Pereira HA, Rossi A, Sena JA, Silva C, de Souza RF, Spinola LA, Takita MA, Tamura RE, Teixeira EC, Tezza RI, Trindade dos Santos M, Truffi D, Tsai SM, White FF, Setubal JC, Kitajima JP: Comparison of the genomes of two Xanthomonas pathogens with differing host specificities. Nature. 2002 May 23;417(6887):459-63.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6394

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
17277.6

# Drug_Target_2_Name:
Bacterioferritin comigratory protein

# Drug_Target_2_Number_of_Residues:
160

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00578	AhpC-TSA

# Drug_Target_2_Protein_Sequence:
>Bacterioferritin comigratory protein
MTDAVLELPAATFDLPLSLSGGTQTTLRAHAGHWLVIYFYPKDSTPGCTTEGLDFNALLP
EFDKAGAKILGVSRDSVKSHDNFCAKQGFAFPLVSDGDEALCRAFDVIKEKNMYGKQVLG
IERSTFLLSPEGQVVQAWRKVKVAGHADAVLAALKAHAKQ

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q8P9V9

# Drug_Target_2_SwissProt_Name:
Q8P9V9_XANCP

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
7.04

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04640
